Next Health vs TeltraCare

Official site exposes broad service coverage across NAD+, IV therapy, hormone optimization, peptides, and memberships.

Membership pages make recurring optimization plans easier to compare than many clinic-first competitors.

Large location footprint supports provider, service, and local-intent pages.

Hormone optimization pricing is less explicit than membership pricing.

Official site clearly positions TeltraCare around hrt and broader longevity support.

Telehealth availability makes it easier to compare remote-care convenience against clinic-led alternatives.

Published service framing is strong enough to support provider, comparison, and location pages.

Membership structure can make the first visible price look cleaner than the full long-term cost.

Next Health: Hormone optimization pricing is less explicit than membership pricing.

TeltraCare: Membership structure can make the first visible price look cleaner than the full long-term cost.

Next Health has the cleaner current edge if you care most about transparency and a broader decision trail.

TeltraCare may still fit better if its geography, clinic structure, or narrower service mix is closer to what you want.

Both providers share HRT — compare pricing models for those specific services before deciding.

Next Health: Medication changes, shipping, or higher treatment tiers may still change the final bill.

TeltraCare: Labs, medication fulfillment, consults, or shipping may sit outside the headline price.

Next Health: Cancellation terms were not clearly listed on the reviewed public pages.

TeltraCare: Official policy pages reference cancellation, refund, or renewal terms, but buyers should still verify the exact current policy before enrolling.

Next Health: Next Health publicly separates non-member IV pricing from membership pricing.

TeltraCare: Women who want another menopause-specific telehealth option beyond the biggest national brands.

Next Health: Official pages list IV drips at $199 for non-members, a $299/month membership tier with 2 IV sessions, and NAD+ IV pricing from $500 to $1,000 depending on dose.

TeltraCare: TeltraCare shows a visible starting price of $99 per month, but deeper pricing detail is not fully public on the reviewed pages.

Next Health: No mandatory membership fee is clearly highlighted in the normalized source data.

TeltraCare: A recurring membership or subscription appears to be part of the offer, but the exact public fee still needs manual review.

Next Health: Hormone care is described as starting inside Medicine 4.0 memberships with baseline lab testing included.

TeltraCare: The public flow suggests clinician review or consultation before treatment begins.

Next Health: Insurance handling was not clearly listed on the reviewed public pages.

TeltraCare: Payment, privacy, or billing-policy pages were reviewed, but insurance, HSA, or FSA handling should still be confirmed directly.

Next Health: Medication changes, shipping, or higher treatment tiers may still change the final bill.

TeltraCare: Labs, medication fulfillment, consults, or shipping may sit outside the headline price.